Brain Monitoring Market Size - Global Growth Forecast 2030

Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Procedure Type, Application & End-User

The global brain monitoring market will witness a robust CAGR of 7.2%, valued at $5.78 billion in 2021, expected to appreciate and reach $10.09 billion by 2030, confirms Strategic Market Research. A brain monitoring device helps monitor electrical and neural activity in the brain. In addition, they help track the blood flow in the veins and arteries situated in the brain. For instance, using the intracranial pressure test (ICP), doctors can determine the cause of your symptoms by checking the cerebrospinal fluid pressure (CSF). The cognitive impairment following surgery and general anesthesia is another type of brain disorder common among elderly patients and is predictive of short- and long-term outcomes. The conditions of cognitive function include postoperative delirium (POD) and postoperative cognitive dysfunction (POCD). Various devices and brain sensors have been developed to monitor such dysfunction; for example, the Massimo SedLine is a device used to evaluate the brain function of individuals under anesthesia and sedation in an operating room and intensive care unit. The factors responsible for driving the brain monitoring market are the growing prevalence and incidence of neurological disorders and the Increasing incidence of traumatic brain injury. According to a study by The Lancet Public health, in 2017, 21.0 million DALYs attributable to neurological disorders occurred in the E.U. and 41.1 million in the WHO European area, and 1.1 million deaths occurred in the EU 1.97 million deaths occurred in the WHO European region. In the E.U., neurological disorders ranked third after cardiovascular diseases and cancers, representing 13.3% of total DALYs and 19.5% of total deaths.

Market Drivers - Increasing Numbers of Neurological Disorders Worldwide, The Rising Application of Minimally Invasive and Non-Invasive Devices in Healthcare

In the past few years, the rising incidence of neurological disorders caused by changing lifestyles, rising levels of stress, and significant changes in the social environment have all contributed to the growth of the market. In addition, patients with Alzheimer's, epilepsy, multiple sclerosis, and brain tumors have been using these devices to understand their conditions. In a report by WHO on 20 June 2019, epilepsy affects 50 million people globally; it is, therefore, one of the most prevalent neurological disorders. More than 80% of epilepsy patients live in low- and middle-income countries. According to some estimates, up to 70% of people with epilepsy can live seizure-free with proper diagnosis and treatment.

Consequently, the rising number of patients with these disorders is likely to drive the growth of the global market for brain monitoring devices. In 2017, data from the Global Burden of Disease Study showed that stroke, Alzheimer's disease, dementia, and migraines were the three most burdensome neurological disorders in the United States. The pressure reactivity index, PRx, is one of the various pieces of equipment that evaluates cerebral autoregulation& cerebral blood flow monitoring in the intensive care unit for severe traumatic brain injury patients or patients with subarachnoid haemorrhage, intending to maintain brain blood flow levels. Furthermore, during the forecast period, technological advances are expected to drive market growth.

Restraints - High Cost Associated with Research and Development of Complex Brain Monitoring Devices

A major restraining factor of the global brain monitoring devices market is the high cost of brain observation surgeries and devices, especially in developing countries with poor reimbursement policies. It is challenging to use brain monitoring devices without the assistance of a skilled professional, and the procedures are generally costly.

Opportunity - The Growing Healthcare Market in Emerging Economies, Government Initiatives to Boost the Development of Minimally Invasive and Non-Invasive, and the Increasing Demand for Minimally Invasive and Non-invasive Devices

There are several government initiatives aimed at the development of novel and innovative technologies, including BRAIN, which was started in the U.S. in April 2013 to encourage brain-related R&D. BRAIN is a non-invasive neural intervention initiative developed by the Advanced Research Projects Activity (IARPA) to improve reasoning and problem-solving.

Since non-invasive and invasive devices have many advantages, non-invasive devices such as ICP monitors, tympanic membrane displacement procedures, TCD devices, optic nerve sheath diameter measurement, C.T. scans/MRI, and fundoscopy have seen a dramatic increase in demand, as they offer a reliable alternative to invasive techniques, requiring players in the industry to develop and market such products.

Market Analysis Of Different Segments Covered in the Report

Product Analysis & Insights

Device

Melectroencephalography (EEG) devices

Magnetoencephalography (MEG) devices

Transcranial Doppler (TCD) devices

Intracranial pressure (ICP) monitors

Cerebral oximeters

Magnetic resonance imaging (MRI) devices

Computerized tomography (C.T.) devices

Positron emission tomography (PET) devices

Sleep monitoring devices

Electromyography (EMG) devices

Accessories

Electrodes

Sensors

Pastes & gels

Caps

Cables

Batteries

Others

The market for brain monitoring devices and accessories is segmented based on product type. The devices segment will dominate the brain monitoring market in 2020, accounting for 76.3% of market revenue. The region is overwhelming due to several factors, such as the increasing incidence of neurological, neurodegenerative, sleep, and psychotic disorders, the need for early diagnosis, the availability of portable and wearable monitoring devices that can be carried at home, and the increased awareness of patients.

Among the devices, the EEG segment will dominate the market in 2020. Over the forecast period, the market will remain dominant due to growing demand for advanced imaging techniques and an increase in investments by device manufacturers—furthermore, the surge for the diagnosis of critical disorders such as epilepsy. Moreover, the recent development of EEG devices and Continuous electroencephalography(cEEG) devices to measure brain activity has encouraged companies to develop these devices. EEG devices are used in continuous cerebral function monitoring to assess brain health and increased use of these devices in the neonatal intensive care unit (NICU). In addition, at the bedside, near-infrared spectroscopy (NIRS) can continuously monitor regional tissue oxygenation without invasive methods. Brain wave monitor, brain activity monitor, brain tissue oxygen monitor, and brain monitors for seizures are some of the devices used for EEG tests.

Procedure Analysis & Insights

Invasive

Non-invasive

According to the forecast, growth in the non-invasive segment will be the fastest due to a rise in traumatic brain injuries, the high acceptance rate of minimally invasive devices, and the low mortality rate. Also, the emerging technology in the non-invasive segment, for instance, Near-infrared diffuse correlation spectroscopy (NIR-DCS), can simultaneously measure oxygen delivery and utilization from the skeletal muscle microvasculature during exercise. Although NIR-DCS can monitor acute changes in oxygen delivery and utilization, it has not yet been fully validated. These developments are increasing the demand for these products, which leads to market growth.

Application Analysis & Insights

Traumatic brain injury (TBI)

Stroke

Dementia

Headache disorders

Sleep disorders

Parkinson's disease

Epilepsy

Huntington's disease

Other diseases

In terms of applications, traumatic brain injury (TBI) dominates the brain monitoring devices market. A large part of the growth of this market segment can be attributed to the increasing incidence of traumatic brain injuries worldwide, which is resulting in high demand for brain monitoring devices in the management of these cases.

End-User Analysis & Insights

Hospitals

Neurology Centres

Clinics&ASC

The hospital segment dominated the global brain monitoring market share in 2020 at 61.4%. Monitoring the brain is a complicated process, requiring advanced and expensive devices primarily found in hospitals. Compared to small clinics and other users, hospitals receive a considerably more significant inflow of patients. Additionally, hospitals have sufficient resources to cover the cost of maintaining brain monitoring devices.

Regional Analysis & Insights

North-America

Asia-Pacific

Europe

LAMEA

As North America has a robust healthcare infrastructure, analysts predict the region will lead the global market and have around 39.7 percent of the total market share. The high adoption of technologies and increased penetration of mobile devices have provided this market with a competitive advantage. Additionally, the supportive regulatory framework and affordable healthcare plans encourage the demand for brain monitoring devices in North America. Further, the growth of the senior population has contributed to the development of the North American market for brain monitoring devices. Furthermore, the rising awareness of the benefits of brain monitoring devices to treat sleep disorders, Alzheimer's disease, and epilepsy, among other conditions, will also encourage growth in the regional market.

Global Brain Monitoring Market Competitive Landscape Analysis

Key Players in the Market are as follows:

Advanced Brain Monitoring, Inc.

Drägerwerk Ag & Co. Kgaa

Masimo Corporation

Cadwell Industries, Inc.

Neurowave Systems, Inc.

Neurosoft

Cgx (A Cognionics Company)

Natus Medical, Inc.

Nihon Kohden Corporation

Philips Healthcare

Ge Healthcare

Siemens Healthineers

Compumedics Limited

Medtronic Plc

Edwards Lifesciences

SpiegelbergGmbh& Co. Kg.

Integra Lifesciences

Other Players

Global Brain Monitoring Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 5.78 billion

The revenue forecast in 2030

USD 10.09 billion

Growth rate

CAGR of approximately 7.2%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

Based on product, Based on the procedure, Based on application, Based on End-User, Based on Regional

Based on Product

Device (Melectroencephalography (EEG) devices, Magnetoencephalography (MEG) devices, Transcranial Doppler (TCD) devices, Intracranial pressure (ICP) monitors, Cerebral oximeters, Magnetic resonance imaging (MRI) devices, Computerized tomography (C.T.) devices, Positron emission tomography (PET) devices, Sleep monitoring devices, Electromyography (EMG) devices) , Accessories (Electrodes, Sensors, Pastes & gels, Caps, Cables, Batteries, Others )

Based on the procedure

Invasive, Non-invasive

Based on Application

Traumatic brain injury (TBI), Stroke, Dementia, Headache disorders, Sleep disorders, Parkinson's disease, Epilepsy, Huntington's disease, Other diseases

Based on End-User

Hospitals, Neurology Centres, Clinics&ASC

Regional Analysis

North America, Asia-Pacific, Europe, LAMEA

Country Scope

United States of America, Mexico, United Arab Emirates, United Kingdom, Germany, France, Canada, China, India, Japan, South Korea, Brazil, Argentina, Saudi Arabia, South Africa

Company Usability Profiles

Advanced Brain Monitoring, Inc., Drägerwerk Ag & Co. Kgaa, Masimo Corporation, Cadwell Industries, Inc., Neurowave Systems, Inc., Neurosoft, Cgx (A Cognionics Company), Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, Ge Healthcare, Siemens Healthineers, Compumedics Limited, Medtronic Plc, Edwards Lifesciences, SpiegelbergGmbh& Co. Kg., Integra Lifesciences, Other Players

Recent Development:

In March 2019, With the CE Mark approval of its SedLine brain function monitor, Massimo (U.S.) provided a solution to assess the brain's health during anesthesia in pediatric patients ages one to 18.

In March 2018, Nihon Kohden (Japan) released the aireeg WEE-1200, a wireless epilepsy monitoring device. It provides real-time epilepsy monitoring in emergency rooms, long-term epilepsy monitoring, and routine EEG monitoring.

The Essential Brain Monitoring Devices that Market Leaders Develop

Name of the product

Function

Key Players

NatusBrain Monitor

The Natus Brain Monitor offers next-generation amplifying technology for EEG, long-term monitoring, and ICU studies.

Natus Medical, Inc.

SedlineMonitor

using electroencephalography (EEG) signals, The Masimo Sedline brain monitor helps clinicians monitor the condition of the brain during anaesthesia

Masimo Corporation

BIS Complete 4-Channel Monitor

This type of imaging allows for the detection of hemispheric differences in the brain, allowing for more advanced monitoring.

Medtronic Plc

Frequently Asked Question About This Report

The current size of the worldwide brain monitoring market is estimated to be around USD 5.62 bn.

End-users of the brain monitoring market are Hospitals, Neurology Centres and Clinics & ASC.

Significant drivers of the brain monitoring market are the growing prevalence and incidence of neurological disorders, increasing knowledge about neurodegenerative ailments, increasing incidence of traumatic brain injury, Increasing usage of brain monitoring for trial purposes in the clinics, etc.

Leading players covered in this report are Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, Ge Healthcare, Siemens Healthineers, Compumedics Limited, Medtronic Plc, Edwards Lifesciences Corporation, Advanced Brain Monitoring, Inc., Drägerwerk Ag & Co. Kgaa, Masimo Corporation, SpiegelbergGmbh& Co. Kg., Cadwell Industries, Inc., Neurowave Systems, Inc., Neurosoft, Cgx (A Cognionics Company), Integra Lifesciences and Other Players.

Asia-Pacific region is estimated to have the highest growth rate worldwide.

NorthAmerica is estimated to have the largest market share among all the regions.

Sources

https://pubmed.ncbi.nlm.nih.gov/33007212/

https://www.who.int/news-room/fact-sheets/detail/epilepsy

1. Introduction

1.1. Study Objective

1.2. Market Definition

1.3. Study Scope

1.3.1. Markets Covered

1.3.2. Geographic Scope

1.3.3. Years Considered

1.3.4. Stakeholders

2. Research Methodology

2.1. Data Procurement

2.2. Paid Database

2.2.1. Secondary Data

2.2.1.1. Key Secondary sources

2.2.2. Primary Data

2.2.2.1 Primary sources

2.2.2.2. Key industry insights

2.2.2.3. Primary interviews with experts

2.2.2.4. Key primary respondent list

2.3. Market Size Estimation

2.4. Bottom-Up and Top-Down Approaches

2.4.1. Bottom-Up Approach

2.4.1.1. Approach for arriving at market size by bottom-up analysis

2.4.2. Top-Down Approach

2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis

2.5. Market Breakdown and Data Triangulation

2.6. Research Methodology

2.7. Risk Assessment

3. Executive Summary

3.1 Post-Covid-19

3.1.1 Actual Scenario

3.1.2 Pessimistic Scenario

3.1.3 Optimistic Scenario

3.1.4 Market Summary

4. Industry Outlook

4.1 Market Snapshot

4.2 Global Brain Monitoring Market

4.2.1 Global market, 2021 – 2030 (USD Million)

4.3 Regional Business Analysis

4.3.1 Global market, by region, 2021 - 2030 (USD Million)

4.4 By Product Business Analysis

4.4.1 Global market, By Product, 2021 - 2030 (USD Million)

4.5 By End-User Business Analysis

4.5.1 Global market, By End-User, 2021 - 2030 (USD Million)

4.6 Application Business Analysis

4.6.1 Global market, By Application, 2021 - 2030 (USD Million)

4.6 Procedure Business Analysis

4.6.1 Global market, By Procedure, 2021 - 2030 (USD Million)

4.7 Value Chain Analysis

4.8 Market Variable Analysis

4.8.1 Market Drivers Analysis

4.8.2 Market Restraints Analysis

4.9 Business Environment Analysis Tool

4.9.1 market PEST analysis

4.9.2 market Porter’s analysis

4.10 Penetration & Growth Prospect Mapping

5. Market Dynamics

5.1. Introduction

5.2. Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Opportunities

5.2.4. Challenges

5.3. Impact of Covid-19 On Market

5.4. Value Chain Analysis

5.5. Ecosystem

5.6. Patent Analysis

5.7. Trade Analysis

5.8. Tariff Analysis

5.9. Case Study Analysis

5.10. Porter’s Five Forces Analysis

5.10.1 Threat of New Entrants

5.10.2 Threat of Substitutes

5.10.3 Bargaining Power of Buyers

5.10.4 Bargaining Power of Suppliers

5.10.5 Degree of Competition

5.11. Procedure Analysis

5.11.1. Trends in Procedure (2014-2021)

5.11.2. Trends in Procedure (2021-2030)

5.12. Pricing Analysis

5.12.1. Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

6.1. Company Market Share Analysis

6.2. Manufacturers Manufacturing Sites, Area Served, Product Product

6.3. Market Competitive Situation and Trends

6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Market: By Product Segment Analysis

7.1. Introduction

7.2. Sales Volume & Revenue Analysis (2021-2030)

7.3. Device

7.3.1. Device market, 2021 - 2030 (USD Million)

7.3.1.1 Melectroencephalography (EEG) devices market, 2021 - 2030 (USD Million)

7.3.1.2 Magnetoencephalography (MEG) devices market, 2021 - 2030 (USD Million)

7.3.1.3 Transcranial Doppler (TCD) devices market, 2021 - 2030 (USD Million)

7.3.1.4 Intracranial pressure (ICP) monitors market, 2021 - 2030 (USD Million)

7.3.1.5 Cerebral oximeters market, 2021 - 2030 (USD Million)

7.3.1.6 Magnetic resonance imaging (MRI) devices market, 2021 - 2030 (USD Million)

7.3.1.7 Computerized tomography (C.T.) devices market, 2021 - 2030 (USD Million)

7.3.1.8 Positron emission tomography (PET) devices market, 2021 - 2030 (USD Million)

7.3.1.9 Sleep monitoring devices market, 2021 - 2030 (USD Million)

7.3.1.10 Electromyography (EMG) devices market, 2021 - 2030 (USD Million)

7.4. Accessories

7.4.1. Accessories market, 2021 - 2030 (USD Million)

7.4.1.1 Electrodes market, 2021 - 2030 (USD Million)

7.4.1.2 Sensors market, 2021 - 2030 (USD Million)

7.4.1.3 Pastes & gels market, 2021 - 2030 (USD Million)

7.4.1.4 Caps market, 2021 - 2030 (USD Million)

7.4.1.5 Cables market, 2021 - 2030 (USD Million)

7.4.1.6 Batteries market, 2021 - 2030 (USD Million)

7.4.1.7 Others market, 2021 - 2030 (USD Million)

8. Global Market: By End-User Segment Analysis

8.1. Introduction

8.2. Sales Volume & Revenue Analysis (2021-2030)

8.3. Hospitals

8.3.1. Hospitals market, 2021 - 2030 (USD Million)

8.4. Neurology Centres

8.4.1. Neurology Centres market, 2021 - 2030 (USD Million)

8.5. Clinics & ASC

8.5.1. Clinics & ASC market, 2021 - 2030 (USD Million)

9. Global Market: By Application Segment Analysis

9.1. Introduction

9.2. Sales Volume & Revenue Analysis (2021-2030)

9.3. Traumatic brain injury (TBI)

9.3.1. Traumatic brain injury (TBI) market, 2021 - 2030 (USD Million)

9.4. Stroke

9.4.1. Stroke market, 2021 - 2030 (USD Million)

9.5. Dementia

9.5.1. Dementia market, 2021 - 2030 (USD Million)

9.6. Headache disorders

9.6.1. Headache disorders market, 2021 - 2030 (USD Million)

9.6. Sleep disorders

9.6.1. Sleep disorders market, 2021 - 2030 (USD Million)

9.7. Parkinson's disease

9.7.1. Parkinson's disease market, 2021 - 2030 (USD Million)

9.8. Epilepsy

9.8.1. Epilepsy market, 2021 - 2030 (USD Million)

9.9. Huntington's disease

9.9.1. Huntington's disease market, 2021 - 2030 (USD Million)

9.10. Other diseases

9.10.1. Other diseases market, 2021 - 2030 (USD Million)

10. Global Market: By Procedure Segment Analysis

10.1. Introduction

10.2. Sales Volume & Revenue Analysis (2021-2030)

10.3. Invasive

10.3.1. Invasive market, 2021 - 2030 (USD Million)

10.4. Non-invasive

10.4.1. Non-invasive market, 2021 - 2030 (USD Million)

11. Global Market: Regional Outlook

11.1 North America

11.1.1. North America market, by By Product, 2021 - 2030 (USD Million)

11.1.2. North America market, by By End-User, 2021 - 2030 (USD Million)

11.1.3. North America market, by Procedure, 2021 - 2030 (USD Million)

11.1.4. North America market, by Country, 2021 - 2030 (USD Million)

11.1.4.1. U.S.

11.1.4.1.1. U.S. market, by By Product, 2021 - 2030 (USD Million)

11.1.4.1.2. U.S. market, by By End-User, 2021 - 2030 (USD Million)

11.1.4.1.3. U.S. market, by Procedure, 2021 - 2030 (USD Million)

11.1.4.2. Canada

11.1.4.2.1. Canada market, by By Product, 2021 - 2030 (USD Million)

11.1.4.2.2. Canada market, by By End-User, 2021 - 2030 (USD Million)

11.1.4.2.3. Canada market, by Procedure, 2021 - 2030 (USD Million)

11.2. Europe

11.2.1. Europe market, by By Product, 2021 - 2030 (USD Million)

11.2.2. Europe market, by By End-User, 2021 - 2030 (USD Million)

11.2.3. Europe market, by Procedure, 2021 - 2030 (USD Million)

11.2.4. Europe market, by country, 2021 - 2030 (USD Million)

11.2.4.1 U.K.

11.2.4.1.1. U.K. market, by By Product, 2021 - 2030 (USD Million)

11.2.4.1.2. U.K. market, by By End-User, 2021 - 2030 (USD Million)

11.2.4.1.3. U.K. market, by Procedure, 2021 - 2030 (USD Million)

11.2.4.2. Germany

11.2.4.2.1. Germany market, by By Product, 2021 - 2030 (USD Million)

11.2.4.2.2. Germany market, by By End-User, 2021 - 2030 (USD Million)

11.2.4.2.3. Germany market, by Procedure, 2021 - 2030 (USD Million)

11.2.4.3. France

11.2.4.3.1. France market, by By Product, 2021 - 2030 (USD Million)

11.2.4.3.2. France market, by By End-User, 2021 - 2030 (USD Million)

11.2.4.3.3. France market, by Procedure, 2021 - 2030 (USD Million)

11.2.4.4. Rest of Europe

11.2.4.4.1. Rest of Europe market, by By Product, 2021 - 2030 (USD Million)

11.2.4.4.2. Rest of Europe market, by By End-User, 2021 - 2030 (USD Million)

11.2.4.4.3. Rest of Europe market, by Procedure, 2021 - 2030 (USD Million)

11.3. Asia Pacific

11.3.1. Asia Pacific market, by By Product, 2021 - 2030 (USD Million)

11.3.2. Asia Pacific market, by By End-User, 2021 - 2030 (USD Million)

11.3.3. Asia Pacific market, by Procedure, 2021 - 2030 (USD Million)

11.3.4. Asia Pacific market, by country, 2021 - 2030 (USD Million)

11.3.4.1. China

11.3.4.1.1. China market, by By Product, 2021 - 2030 (USD Million)

11.3.4.1.2. China market, by By End-User, 2021 - 2030 (USD Million)

11.3.4.1.3. China market, by Procedure, 2021 - 2030 (USD Million)

11.3.4.2. India

11.3.4.2.1. India market, by By Product, 2021 - 2030 (USD Million)

11.3.4.2.2. India market, by By End-User, 2021 - 2030 (USD Million)

11.3.4.2.3. India market, by Procedure, 2021 - 2030 (USD Million)

11.3.4.3. Japan

11.3.4.3.1. Japan market, by By Product, 2021 - 2030 (USD Million)

11.3.4.3.2. Japan market, by By End-User, 2021 - 2030 (USD Million)

11.3.4.3.3. Japan market, by Procedure, 2021 - 2030 (USD Million)

11.3.4.4. South Korea

11.3.4.4.1. South Korea market, by By Product, 2021 - 2030 (USD Million)

11.3.4.4.2. South Korea market, by By End-User, 2021 - 2030 (USD Million)

11.3.4.4.3. South Korea market, by Procedure, 2021 - 2030 (USD Million)

11.3.4.5. Rest of ASIA PACIFIC

11.3.4.5.1. Rest of ASIA PACIFIC market, by By Product, 2021 - 2030 (USD Million)

11.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021 - 2030 (USD Million)

11.3.4.5.3. Rest of ASIA PACIFIC market, by Procedure, 2021 - 2030 (USD Million)

11.4. Latin America

11.4.1. Latin America market, by By Product, 2021 - 2030 (USD Million)

11.4.2. Latin America market, by By End-User, 2021 - 2030 (USD Million)

11.4.3. Latin America market, by Procedure, 2021 - 2030 (USD Million)

11.4.4. Latin America market, by country, 2021 - 2030 (USD Million)

11.4.4.1. Brazil

11.4.4.1.1. Brazil market, by By Product, 2021 - 2030 (USD Million)

11.4.4.1.2. Brazil market, by By End-User, 2021 - 2030 (USD Million)

11.4.4.1.3. Brazil market, by Procedure, 2021 - 2030 (USD Million)

11.4.4.2. Mexico

11.4.4.2.1. Mexico market, by By Product, 2021 - 2030 (USD Million)

11.4.4.2.2. Mexico market, by By End-User, 2021 - 2030 (USD Million)

11.4.4.2.3. Mexico market, by Procedure, 2021 - 2030 (USD Million)

11.4.4.3. Rest of the Latin America

11.4.4.3.1. Rest of the Latin America market, by By Product, 2021 - 2030 (USD Million)

11.4.4.3.2. Rest of the Latin America market, by By End-User, 2021 - 2030 (USD Million)

11.4.4.3.3. Rest of the Latin America market, by Procedure, 2021 - 2030 (USD Million)

11.5. MEA

11.5.1. MEA market, by By Product, 2021 - 2030 (USD Million)

11.5.2. MEA market, by By End-User, 2021 - 2030 (USD Million)

11.5.3. MEA market, by Procedure, 2021 - 2030 (USD Million)

11.5.4. MEA market, by Region, 2021 - 2030 (USD Million)

12. Competitive Landscape

12.1 Corporation

12.1.1. Company overview

12.1.2. Financial performance

12.1.3. Product Portfolio Analysis

12.1.4. Business Strategy & Recent Development

12.2. Advanced , Inc

12.2.1. Company overview

12.2.2. Financial performance

12.2.3. Product Portfolio Analysis

12.2.4. Business Strategy & Recent Development

12.3. Drägerwerk Ag & Co. Kgaa

12.3.1. Company overview

12.3.2. Financial performance

12.3.3. Product Portfolio Analysis

12.3.4. Business Strategy & Recent Development

12.4. Masimo Corporation

12.4.1. Company overview

12.4.2. Financial performance

12.4.3. Product Portfolio Analysis

12.4.4. Business Strategy & Recent Development

12.5. Cadwell Industries, Inc

12.5.1. Company overview

12.5.2. Financial performance

12.5.3. Product Portfolio Analysis

12.5.4. Business Strategy & Recent Development

12.6. Neurowave Systems, Inc

12.6.1. Company overview

12.6.2. Financial performance

12.6.3. Product Portfolio Analysis

12.6.4. Business Strategy & Recent Development

12.7. Neurosoft

12.7.1. Company overview

12.7.2. Financial performance

12.7.3. Product Portfolio Analysis

12.7.4. Business Strategy & Recent Development

12.8. Cgx (A Cognionics Company)

12.8.1. Company overview

12.8.2. Financial performance

12.8.3. Product Portfolio Analysis

12.8.4. Business Strategy & Recent Development

12.9. Natus Medical, Inc

12.9.1. Company overview

12.9.2. Financial performance

12.9.3. Product Portfolio Analysis

12.9.4. Business Strategy & Recent Development

12.10. Nihon Kohden Corporation

12.10.1. Company overview

12.10.2. Financial performance

12.10.3. Product Portfolio Analysis

12.10.4. Business Strategy & Recent Development

12.11. Philips Healthcare

12.11.1. Company overview

12.11.2. Financial performance

12.11.3. Product Portfolio Analysis

12.11.4. Business Strategy & Recent Development

12.12. Ge Healthcare.

12.12.1. Company overview

12.12.2. Financial performance

12.12.3. Product Portfolio Analysis

12.12.4. Business Strategy & Recent Development

12.13. Siemens Healthineers

12.13.1. Company overview

12.13.2. Financial performance